Fetal Alcohol Research (FAR) - The official journal of the FACE Research Network

Advancing FASD prevention and care through research

On November 1, 2007, the Journal of FAS International - JFAS Int - was amalgamated with the Canadian Journal of Clinical Pharmacology, a peer-review, on-line journal @ www.cjcp.ca. The Section in the amalgamated Journal dedicated to FASD is called Fetal Alcohol Research (FAR). This amalgamation will ensure that original research published in CJCP/FAR will be cited in PubMed - Medline, hence increasing the exposure of new findings in fetal alchol research within the scientific community.

Past issues of the Journal of FAS International will be maintained in the JFAS archives. You may view them any time. We will also continue to post the FACE Research Roundtable Webcasts, Scientific News andConferences and Events notices @ http://www.motherisk.org/FAR. So keep that page bookmarked.

FASD is the most prevalent cause of developmental delay and brain insult. Affecting an estimated 0.3% to 1% of all offspring, victims of FASD face debilitating, and often devastating effects that last a lifetime. Unlike other developmental brain impairment,the etiology of FASD is known. Yet progress in prevention, diagnosis and management has been painfully slow. Many factors need to be addressed, including the role of poverty, homelessness, psychiatric morbidity, social disparity, other drugs of abuse, poor nutrition and lack of medical care during pregnancy. It is our hope that this new journal and on-line resource will advance the search for new knowledge and solutions.

The amalgamated CJCP/FAR will continue to be web-based and freely available to clinicians, researchers, teachers, individuals affected by FASD (including parents, partners, siblings), program providers, community leaders and the public at large. We hope you find the content and format of Fetal Alcohol Research (FAR) useful in your practice, research and programs. We welcome your ideas about how to improve FAR and invite you to submit papers and letters.

Cordially,
Gideon Koren, MD, FABMT, FRCPC
Director, The Motherisk Program
Professor of Paediatrics, Pharmacology, Pharmacy, Medicine and Medical Genetics, The University of Toronto
Senior Scientist, The Research Institute, The Hospital for Sick Children, Toronto, Canada
The Ivey Chair in Molecular Toxicology, University of Western Ontario, Canada